Magnetic Separation Methods for the Detection of Mycobacterium avium subsp. paratuberculosis in Various Types of Matrices: A Review.
Paratuberculosis (Johne's disease) is a chronic granulomatous enteritis caused by Mycobacterium avium subsp. paratuberculosis (MAP). The bacterium infects mainly domestic animals such as cattle, sheep, and goats but also wildlife species (e.g., deer) . Animals are usually infected at a young age through contaminated feces, colostrum, and milk or via contaminated feed . The early detection of Johne's disease is difficult because of the long incubation period, which can last 2-10 years before clinical symptoms appear . The progressive stage of infection is characterized by diarrhea and loss of body weight, which can end in death. This results in lower meat and milk yields, and thus paratuberculosis causes significant financial losses to farmers worldwide . MAP is spread mainly through milk and feces . In 2007,68.1% of U.S. dairy operations were infected with MAP and the National Animal Health Monitoring System released a report highlighting the importance of this disease .
Animals with clinical signs represent only a small proportion of the infected animals within a herd. Those with subclinical disease and thus no clinical symptoms can remain undetected for years during which time, as carriers of MAP, they can shed the infectious agent into the external environment [5, 6]. Successful control of paratuberculosis has been difficult because commonly used diagnostic tests are not accurate until the later stage of infection [7, 8].
Different kinds of matrices, such as feces, milk, milk products, colostrum, environmental samples, milk filters, tissue, or blood can be used for the detection of MAP. Feces and milk represent the most commonly tested matrices. However, due to the presence of many inhibitory substances, the usage of extracted DNA from these test matrices can be complicated. In milk and colostrum, fat and high concentrations of milk protein represent the major problem. Redundant substances from feed, phytic acid, and polysaccharides in feces can inhibit DNA amplification [9, 10]. Thus, appropriate sample preparation prior to PCR detection is crucial. For these purposes, new and more sensitive MAP DNA isolation methods based on magnetic separation procedures (immunomagnetic separation and peptide-mediated magnetic separation) have been developed. Commercially available kits with specific reagents remove PCR inhibitors or have greatly improved DNA capture technology by using DNA or cell-binding paramagnetic beads or DNA filters .
The aim of this review is to summarize all of the available information regarding MAP cells and DNA isolation methods based on magnetic separation procedures for the detection of MAP from a broad range of matrices.
2. Brief Overview of Commonly Used Detection Methods of MAP
There are several methods used for the detection of MAP in infected animals. Cultivation with chemical decontamination was one of the first methods to be developed for MAP detection. Despite the fact that more rapid methods for MAP detection have been reported in recent years, culture is still considered to be the "gold standard" even though the method is slow (the incubation of MAP on solid medium lasts at least 3 months), is labour intensive, and has limited sensitivity .
The popularity of the polymerase chain reaction (PCR) for the detection of MAP has risen in recent years. This method is rapid and sensitive and can be designed very specific for the broad range of different organisms. On the other hand, PCR is very sensitive to the presence of inhibitory substances in samples and when applied directly, sensitivity is very low (especially in milk samples, 23%) . Thus, in any direct PCR the extraction method is a critical step . The majority of PCR protocols for MAP detection target the insertion sequence IS900, F57, HspX, or ISMav2 and ISMap04 [15,16].
A disadvantage of the PCR methods used for the detection of MAP is that they cannot distinguish between viable and nonviable bacteria in the analyzed samples. For this reason the phage amplification assay method was developed. The commercially available FASTPlaque TB[TM] assay enables rapid detection of viable MAP within 24-48 h based on the count of plaques produced when mycobacteriophage infected cells burst in a lawn of fast-growing Mycobacterium smegmatis . To obtain sufficient specificity, it is necessary to verify the plaques combining the phage amplification assay with another detection method such as conventional PCR . Peptide-mediated magnetic separation (PMS) can be used prior to phage amplification assay to reduce the complexity of the sample and remove the inhibitors which interfere following PCR, necessarily used for confirmation of specificity . PMS-phage assay can be also combined with ELISA consequently called phage-mediated immunoassay .
The identification of paratuberculosis can be achieved either through identification of the infectious agent or on the basis of the host's immune response (ELISA) . This antibody detection method enables high-throughput and relatively low-cost analysis. However, the sensitivity of MAP-specific ELISA is generally estimated to be below 50%, depends on the stage of disease, and varies between animal species and the tests that are used . The gamma-interferon assay is another immune response detection method used for indirect detection of MAP. This diagnostic test relies on the fact that T-lymphocytes release gamma interferon (INF-[gamma]) when exposed to specific antigens, and the test measures the amount of released INF-[gamma] [21, 22]. However, as protein purified derivate used for the stimulation of the immune system includes antigens shared with other mycobacteria, false-positive results can occur .
3. Magnetic Separation Methods
Magnetic separation (MS) methods involving either antibodies or peptides (Figure 1) were developed in order to introduce specificity for efficient MAP capture. MS-based methods selectively separate the target bacteria from other, nontarget microorganisms and inhibitory sample components while concentrating the target bacterial cells into a smaller volume. However, Foddai et al.  pointed out that not all magnetic separation approaches developed for the selective concentration of MAP perform equally well. The selectivity of capture is assessed by determining the efficiency of capture and depends on the bead characteristics (composition, size, concentration, and surface modification) or the nature of the coating ligand (polyclonal or monoclonal antibody, biotinylated or nonbiotinylated peptide). Capture efficiency, expressed as a percentage, is a measure of the completeness of capture from the original population of target cells present in the sample. Usage of magnetic separation enhances the analytical specificity and sensitivity of the subsequent detection method, which can be culture, PCR, microscopy, an antigen detection immunoassay, or a phage assay .
The major weakness of MS-based methods is nonspecific recovery of other Mycobacterium spp. Foddai et al.  described two types of nonspecific recovery. The first type was observed when uncoated beads were used and the percentage of recovery of nontarget mycobacteria was <10%. This is caused by nonspecific interaction between the surface of paramagnetic beads and bacteria, most likely due to electrostatic bonds or van der Waals forces. The second type of nonspecific recovery, which exceeds 10%, is caused by cross-reaction between the coating ligand (peptide or antibody) and usually closely related nontarget bacteria. Issues with nonspecific recovery could be solved by coating the paramagnetic beads with specific ligands.
Combined MS-based techniques are routinely used for the detection and isolation of pathogenic bacteria such as Listeria monocytogenes , Salmonella spp. , and Escherichia coli  in both food and veterinary clinical samples . In mycobacterial research this approach is still not so commonly used.
MS can be divided, according to the type of capture ligand that is coated onto paramagnetic beads, into immunomagnetic separation and peptide-mediated separation.
The immunomagnetic separation (IMS) method relies on the interaction between cell surface antigens and antibodies coated onto paramagnetic beads. The immune part of the beads is represented either by monoclonal or polyclonal antibodies which selectively capture target bacteria. IMS for MAP, first described by Grant et al. , employs a rabbit polyclonal anti-MAP antibody, which was used to coat sheep anti-rabbit immunoglobulin G (IgG) type M-280 Dynabeads and facilitates selective isolation of MAP cells from milk. IMS is a powerful method for extracting desired organisms from heterogeneous bacterial suspensions; it shows good detection specificity for MAP and high detection sensitivity, although this is very much dependent on the antibody involved. The speed of MAP detection is enhanced by subsequent IS900 PCR use. Immunomagnetic PCR (IMS-PCR) can detect as little as [10.sup.3] CFU/50 mL, which is 1 to 2 [log.sub.10] units lower compared to the number detected by IS900 PCR applied to milk directly . Use of polyclonal antibody IMS-based methods in conjunction with culture lacks, according to Foddai et al.  and sufficient specificity for MAP and nontarget bacteria can overgrow this bacterium in culture. Nevertheless, since no selective medium truly exists, specificity for MAP must be achieved by optimizing the types of beads and capture ligands.
Metzger-Boddien et al.  reported a monoclonal antibody IMS-PCR-based method for MAP as a rapid, standardized, and fully automated technique for routine, large scale diagnostic applications. It was shown that this method is very specific and sensitive in detecting minimal amounts of artificially spiked MAP in milk and overall shows superior effectiveness compared to culture.
Most recently, novel monoclonal antibodies for MAP were successfully developed by O'Brien et al. . This new IMS approach uses MyOne Tosylactivated Dynabeads dually coated with monoclonal antibodies 6G11 and 15D10 and promises improvement in sensitivity of MAP capture. However, successful application will be dependent on the end-point detection method and the author suggests to use culture or phage amplification assay.
Peptide-mediated magnetic separation (PMS) relies on the interaction between MAP-specific peptides (aMptD, aMp3) coupled with paramagnetic beads and surface-exposed MAP proteins (MptD, Mp3). The 12-mer peptides used were originally identified by phage display biopanning of MAP cells using the Ph.D.-12 phage library and are chemically synthesized to achieve high purity before coating onto paramagnetic beads [32, 33].
PMS can be employed together with other methods such as the phage amplification assay. This combination enables rapid enumeration of viable MAP cells within 24 h and is selective for low numbers of MAP. PMS is followed by culture, as a reference method for MAP, but without the need for chemical decontamination . The detection of viable MAP cells and not just MAP DNA is the main advantage of this method over IMS-PCR. Moreover, Foddai et al.  reported that the detection sensitivity of the novel automated PMS-phage assay is comparable to or better than those ofIMS-PCR methods.
Besides novel monoclonal antibodies, O'Brien et al.  generated also new peptide ligands specific for MAP cells and suggested new PMS approach using biotin-EEA402 peptide-coated beads. According to the author, both new IMS and PMS approaches were found to improve the sensitivity of MAP capture compared to the currently used aMp3/aMptD peptide-coated beads. However, these systems are currently under the investigation and need to be applied to matrices to verify their reliable function.
3.1. Use of Magnetic Separation Methods for the Detection of MAP Cells. In the following paragraphs, we describe the use of individual types of MS for the detection of MAP. This information is summarized in tables divided according to the type of matrix used. Another partitioning criterion was whether MAP cells or DNA are detected by MS.
3.2. Detection of MAP Cells in Milk. The isolation of MAP cells from milk is currently performed using either IMS or PMS methods in conjunction with some end-point detection method, most often IS900 PCR, phage assay, ELISA, or culture. The most commonly used type of beads for IMS is M280 sheep anti-rabbit immunomagnetic Dynabeads coated with polyclonal rabbit anti-MAP antibodies (Table 1). Djonne et al.  used Dynabeads and IMS-IS900 PCR for MAP detection in goat milk. The minimal Limit of Detection was determined using unpasteurised cow's milk that was artificially contaminated. Using IMS-IS900 PCR, the minimum detection limit for visualization of a product using ethidium bromide was 1CFU/mL (using dot blot even 0.1CFU/mL), in comparison with culture where the minimum detection limit was 10 CFU/mL milk. This finding confirms the high sensitivity and great potential of the PCR method for future research. Grant et al.  reported 100% sensitivity and 95% specificity of IMS-PCR using Dynabeads coated with polyclonal antibody. In comparison, Metzger-Boddien et al.  achieved 96% sensitivity using AnDiaTec ParaTubS monoclonal antibody-mediated immunomagnetic separation PCR kit in combination with ELISA. This implies that IMS-PCR with Dynabeads is probably the best approach for detection of MAP in milk. Khare et al.  used a different type of bead with rabbit polyclonal anti-MAP antibodies, BioMag goat anti-rabbit IgG, with IS900 qPCR as an endpoint detection method. This rapid technique allowed the detection of ten or fewer MAP cells in 2 mL of milk, making this sensitive procedure very useful and cost-effective for the diagnosis of clinical and subclinical paratuberculosis. Recently, Gilardoni et al.  combined the use of IMS with monoclonal and polyclonal antibodies and modified IS900 (IS1 PCR) to detect MAP DNA. The aim of IS1 PCR is to amplify the IS1 fragment in the IS900 sequence. The IMS-IS1 PCR enabled a Limit of Detection of as low as [10.sup.1] CFU/mL of milk, when a 50:50 mix of monoclonal and polyclonal antibodies was used. This result is better than some of those listed in Table 1, but more investigation of this method is needed.
Dynabeads are the most commonly used beads in PMS studies (Table 1). MyOne Tosylactivated Dynabeads coated with the chemically synthesized MAP-specific biotinylated peptides aMp3 and aMptD were used by Foddai et al. . They achieved 91.5% capture efficiency and minimal (<1%) nonspecific recovery of other Mycobacterium spp. In combination with a phage amplification assay. PMS was performed on 1 mL milk samples using 5 [micro]L biotinylated aMp3 peptide-coated beads and 5 [micro]L biotinylated aMptD peptide-coated beads added separately to each reaction. This novel, rapid method for the detection and enumeration of viable MAP cells in milk was proven to be the best available magnetic separation approach, with results obtainable within 48 h.
Subsequent evaluation of the other types of surface-activated paramagnetic beads showed that MyOne Tosylactivated Dynabeads coated with the S624 polyclonal antibody or peptides achieve a much higher capture efficiency for MAP than other surface-activated beads and that, generally, peptide-coated beads consistently achieve higher capture efficiencies than polyclonal-antibody-coated beads. On the other hand, the poorest capture efficiency was recorded for streptavidin-coated beads and amine-coated hollow glass beads, for which mean capture efficiencies were consistently found to be about 10% .
The aMptD peptide which binds to the MAP MptD protein was used separately but coupled directly (without a biotin-streptavidin bridge) to paramagnetic beads by carbodiimide in peptide-mediated capture ISMav2 PCR . Experiments were based on a competitive capture assay where milk was spiked with MAP; the presence of an excess of other mycobacterial species demonstrated that only MAP had been captured. The results confirmed that the aMptD peptide is highly conserved among different MAP isolates. Independently of the MAP strain, 5 x [10.sup.2] MAP/mL could be reliably detected. Thus, this demonstrates the high specificity of aMptD and its suitability for use as a ligand in diagnostic tests.
Stratmann et al.  reproducibly detected MAP in bulk milk samples using MagneSphere streptavidin paramagnetic beads coated with either phage fMp3 or peptide aMp3 in combination with ISMav2 PCR. The Limit of Detection was found to be [10.sup.2] PFU/mL for fMp3 and [10.sup.1] PFU/mL for aMp3 peptide. As IS900 can exhibit nonspecific reactions, ISMav2, present in only three copies in the genome, was used. Foddai et al.  could detect as little as 0.3 PFU/mL using Dynabeads, suggesting that it might be interesting to test Dynabeads in conjunction with ISMav2 in order to achieve even better results.
3.3. Detection of MAP Cells in Feces. The use of magnetic separation for the isolation of MAP from feces is not common. In the literature, only four publications dealing with this technique can be found (Table 2).
Regarding the methods for the isolation of MAP from feces, PMS with Dynabeads is the most commonly used method. However, in one case, IMS using BioMag goat anti-rabbit IgG with rabbit polyclonal anti-MAP antibodies was performed (Table 2).
In all reports bovine feces were used, and, thus, it remains unclear how the method would work for samples other than bovine feces. Frequently, a sample of feces (from 200 mg to 1 g) is diluted and only the suspension is subject to further analysis. Most often, the sample is diluted with water. Only in one case were undiluted feces taken [35, 37].
For the determination of sensitivity and/or LOD (Limit of Detection), artificially contaminated samples were used. Using the IMS method with BioMag goat anti-rabbit immunoglobulin G [IgG] and rabbit polyclonal anti-MAP antibodies, a LOD of 10 or fewer MAP organisms/200 mg of feces was reached, whereas a sensitivity of 100% was achieved . These results show that this procedure is very sensitive and cost-effective for the isolation and detection of MAP cells from feces. Nonetheless, to rigorously verify this method it will be necessary to test naturally contaminated samples, as well as samples of nonbovine origin.
3.4. Detection of MAP Cells in Blood. The report of Swift et al.  is so far the only available description of the isolation of MAP from clinical blood samples using the PMS-phage method in order to achieve rapid detection of viable MAP (Table 3). To develop the method, 3.5 x [10.sup.1] PFU/mL of MAP were spiked into commercially available horse or sheep blood. In horse blood, no cells were detectable due to its high viscosity. In initial experiments on sheep blood, only 33% of the cells were recovered. Assuming that the blood was inhibiting the peptide binding or phage assay, samples were subsequently diluted. Samples were diluted 10x in modified 7H9 Media Plus and MyOne Tosylactivated Dynabeads coated with biotinylated peptides (5 [micro]L aMp3, 5 [micro]L aMptD) were used. The PMS-phage method combined with IS900 PCR was employed resulting in a Limit of Detection of 10 MAP cells/mL of sheep's blood. Moreover, when a 1 in 50 dilution (using modified 7H9 Media Plus) was used for sheep blood, 73% of MAP cells were recovered. However, a 1 in 10 dilution was set as the standard method as it resulted in 92% capture efficiency. These results proved that this assay is rapid and sensitive and can directly detect viable MAP cells present in naturally infected blood, all within 48 h. However, optimization for blood samples from all susceptible animal species is needed.
3.5. Detection of MAP Cells in Cheese. It has been found that MAP is a bacterium with extraordinary temperature resistance, and in some cases, it can survive pasteurization of milk and the cheese-manufacturing process. These worrying properties have been verified using several techniques such as conventional cultivation or the plaque assay. However, only one publication reports the use of the MS method in this regard. In 2007, the IMS approach with an automatic Pathatrix magnetic capture system was used to detect MAP in raw bovine milk cheese samples (Table 4). Using several levels of MAP contamination, the LOD was determined to be 103 MAP/25 g. Although no viable MAP cells were detected using conventional cultivation, the use of the F57-based real-time PCR system enabled the detection of MAP genetic elements .
3.6. Use of Magnetic Separation Methods for the Detection of MAP DNA. In case of the MAP DNA detection, paramagnetic beads are not coated with MAP-specific ligands and they do not capture only MAP but also other mycobacterial DNA. Specificity is achieved by end-point PCR method.
3.7. Detection of MAP DNA in Milk. As well as the detection of viable MAP cells, direct detection of MAP DNA is also employed. This approach is problematic due to the necessity of obtaining high purity DNA in sufficient amounts for PCR and is complicated by the presence of inhibitors in samples. In order to solve these problems, commercially available kits with DNA capture technology using paramagnetic beads and specific reagents that remove PCR inhibitors have been developed. The study of Donaghy et al.  assessed the performance of a commercially available MAP DNA extraction kit for milk, Adiapure, combined with the Adiavet PCR detection kit. Artificially contaminated raw milk with naturally MAP-infected feces (initial number of MAP cells [10.sup.6]- [10.sup.7]) was used to assess the sensitivity of MAP detection. The sensitivity of detection was found to be 90%, when 30 copies of IS900/mL (equivalent to approximately 2 cells) were detected (Table 5). For 300 copies of MAP, the sensitivity of detection reached 100%. This implies that the commercial Adiapure-Adiavet MAP DNA extraction and PCR detection kit allows consistent and sensitive detection of MAP in milk. In other studies, naturally contaminated milk was used. Herthnek et al.  tested the presence of MAP in bulk tank milk using the EZ1 DNA Tissue Kit with paramagnetic beads automatically processed in the BioRobot[R] EZ1 workstation. The analytical sensitivity was assessed to be 100 MAP/mL for samples of 10 mL (Table 5). Cultured environmental fecal samples (collected from the proximal environment of the cows) were used as a reference and 68% of the herds were positive, while 30% were positive by milk PCR. This result indicates that although MAP may be shed into milk, it will probably be present in low numbers in bulk tank milk due to dilution effects.
3.8. Detection of MAP DNA in Feces. Leite et al.  compared six commercially available extraction kits for detection of MAP DNA using fecal samples from naturally infected cattle. Using the MagMAX Total Nucleic Acid Isolation Kit containing paramagnetic beads, 76% of the positive samples were identified using IS900 PCR (Table 6). Using the same extraction kit, 65% of MAP DNA samples were recovered in the study of Okwumabua et al. . According to these results, and in comparison with other nonparamagnetic methods, MagMAX is considered to be a highly efficient method for the extraction of MAP DNA from fecal samples. The BioSprint 96 One-For-All Vet Kit was used by Plain et al.  for isolation of MAP from fecal samples from cattle and sheep and from sheep tissue samples. The Limit of Detection was calculated to be [10.sup.2]-[10.sup.3] MAP/mL using artificially contaminated sheep fecal samples with initial concentrations of [10.sup.6] to [10.sup.1] MAP/mL.
4. General Comments to the Data in Tables
Based on the number of the publications, the most intensively studied matrix using MS is milk. Almost no information is about the use of MS in blood, tissue, and cheese. In case of feces only one type of the origin of matrix was used. Regarding the composition, fecal matrix differs from one animal species to another; thus the access of MS will be also different (depending on the composition of the feed, consistency). There are no publications about the application of MS in infant milk formulas or another animalderived foodstuff. In the 12th International Colloquium on Paratuberculosis (ICP) in Parma, Italy, there was only one piece of information about the use of MS in infant formulas (page 306; http://www.paratuberculosis.info/images/proc12/ 12icp.pdf). In the 13th ICP, there was one comparative study on PMS-phage assay with milk suppliers presented (page 48, P-03.10). This presentation highlighted the problem of unsuccessful transfer of the PMS-phage assay method between two different laboratories. Up to date, no publications based on these presentations were published. In addition, there is no investigated environmental matrix (environmental fecal samples from manure, scrapes, etc.). There is a big potential to make the screening of the farm easier with unknown history of paratuberculosis.
In case of all mentioned matrices (except for the tissue) the artificial contamination (AC) with MAP was used. This fact is crucial for the future evaluation. The AC could be used for the exact validation of the method for the selected matrix. Unfortunately, not a lot of publications include important data such as Limit of Detection, capture efficiency, and sensitivity. In general, no sufficient volume of the sample is used. In case of milk, only one milliliter does not have a big informative value and with regard to feces, 200 mg is not sufficient as well.
5. Conclusion and Perspectives
Studies published in the last few decades show that the popularity of magnetic separation-based methods has rapidly increased, especially in connection with end-point PCR methods. This trend is due to the fact that MS-based methods are rapid, sensitive, and specific, selectively concentrate target bacteria into smaller volumes, and enable effective removal of PCR-inhibiting compounds. Appropriate sample preparation prior to PCR detection is crucial and for these purposes, new and more sensitive DNA isolation methods have been developed. Obtaining DNA of sufficient concentration and purity for subsequent applications, such as conventional or real-time PCR, represents the main challenges. Therefore, magnetic separation methods remain under development.
The studies discussed in this review document the detection of MAP in milk, feces, cheese, blood, and tissue. Two main approaches are used for the isolation of MAP cells from the above-mentioned matrices, IMS and PMS. For the detection of MAP cells in milk, M-280 sheep antirabbit immunomagnetic Dynabeads coated with polyclonal rabbit anti-MAP antibodies are the most commonly used type of beads for IMS. For the detection of MAP cells in feces, the best results are achieved when IMS is used, but PMS with peptide-coated MyOne Tosylactivated Dynabeads is the most commonly employed method at present. PMS in combination with the phage method has been used to determine the viability of MAP cells in blood; other magnetic separation methods have not been used in blood until now. Similarly as in blood, only one study using a magnetic separation method was conducted in cheese until now. Here, the IMS approach with automatic Pathatrix magnetic capture system wasapplied. For specificcaptureof M APDNA, special commercially available kits with paramagnetic beads are used.
An interesting field where the magnetic separation methods were not used until now at all is infant formulas. This could be a field on which the following research should be focused especially when the reports on the presence of MAP in infant formulas appeared recently. In many cases, detection of MAP using magnetic separation methods has been carried out on artificially contaminated samples. For the development of reliable detection methods, more in-depth investigation and the use of naturally contaminated samples, especially of feces, tissues, and blood, is needed. The potential of the magnetic separation methods is broad. However, the main focus of the following research should be to improve the reliability of the assay for the use in many sectors of dairy and food industry.
The novel diagnostic assays for the detection of MAP discussed in this review are giving promising results. Thus far, the assays have not been validated according to OIE recommendations essential for their deployment in the control of animal infectious diseases as well as safeguarding the food chain. Validating the assays according to the OIE rules and testing their robustness in an interlaboratory study would help to harmonize and standardize the variety of assays, increase their acceptance, and facilitate their use in critical studies in animal disease control and food safety.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this paper.
This work was supported by the projects MA CR RO0516 and LO1218 of MEYS of the Czech Republic under the NPU I program. Neysan Donnelly is thanked for the grammatical correction of the manuscript.
 E. A. Raizman, J. P. Fetrow, and S. J. Wells, "Loss of income from cows shedding Mycobacterium avium subspecies paratuberculosis prior to calving compared with cows not shedding the organism on two Minnesota dairy farms," Journal of Dairy Science, vol. 92, no. 10, pp. 4929-4936, 2009.
 R. J. Whittington and E. Sergeant, "Progress towards understanding the spread, detection and control of Mycobacterium avium subsp paratuberculosis in animal populations," Australian Veterinary Journal, vol. 79, no. 4, pp. 267-278, 2001.
 C. J. Clarke, "The pathology and pathogenesis of paratuberculosis in ruminants and other species," Journal of Comparative Pathology, vol. 116, no. 3, pp. 217-261,1997
 USDA-APHIS, Veterinary Services, C.f.E.a.A. Health, Johnes Disease on U.S. Dairies, 1991-2007, 2008.
 N. J. Gilmour, "The pathogenesis, diagnosis and control of Johne's disease.," Veterinary Record, vol. 99, no. 22, pp. 433-434, 1976.
 E. L. Gulliver, K. M. Plain, D. J. Begg, and R. J. Whittington, "Histopathological Characterization of Cutaneous Delayedtype Hypersensitivity and Correlations with Intestinal Pathology and Systemic Immune Responses in Sheep with Paratuberculosis," Journal of Comparative Pathology, vol. 153, no. 2-3, pp. 67-80, 2015.
 S. S. Nielsen, C. Gronbak, J. F. Agger, and H. Houe, "Maximum-likelihood estimation of sensitivity and specificity of ELIAs and faecal culture for diagnosis of paratuberculosis," Preventive Veterinary Medicine, vol. 53, no. 3, pp. 191-204, 2002.
 D. J. Begg, K. de Silva, K. M. Plain, A. C. Purdie, N. Dhand, and R. J. Whittington, "Specific faecal antibody responses in sheep infected with Mycobacterium avium subspecies paratuberculosis," Veterinary Immunology and Immunopathology, vol. 166, no. 3-4, pp. 125-131, 2015.
 L. Monteiro, D. Bonnemaison, A. Vekris et al., "Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model," Journal of Clinical Microbiology, vol. 35, no. 4, pp. 995998,1997.
 C. G. Thornton and S. Passen, "Inhibition of PCR amplification by phytic acid, and treatment of bovine fecal specimens with phytase to reduce inhibition," Journal of Microbiological Methods, vol. 59, no. 1, pp. 43-52, 2004.
 I. A. Sevilla, J. M. Garrido, E. Molina et al., "Development and evaluation of a novel multicopy-element-targeting triplex PCR for detection of Mycobacterium avium subsp. paratuberculosis in feces," Applied and Environmental Microbiology, vol. 80, no. 12, pp. 3757-3768, 2014.
 I. Slana, F. Paolicchi, B. Janstova, P. Navratilova, and I. Pavlik, "Detection methods for Mycobacterium avium subsp. paratuberculosis in milk and milk products: a review," Veterinarni Medicina, vol. 53, pp. 283-306, 2008.
 I. R. Grant, C. M. Pope, L. M. O'Riordan, H. J. Ball, and M. T. Rowe, "Improved detection of Mycobacterium avium subsp. paratuberculosis in milk by immunomagnetic PCR," Veterinary Microbiology, vol. 77, no. 3-4, pp. 369-378, 2000.
 F. L. Leite, K. D. Stokes, S. Robbe-Austerman, and J. R. Stabel, "Comparison of fecal DNA extraction kits for the detection of Mycobacterium avium subsp. paratuberculosis by polymerase chain reaction," Journal of Veterinary Diagnostic Investigation, vol. 25, no. 1, pp. 27-34, 2013.
 I. Slana, P Kralik, A. Kralova, and I. Pavlik, "On-farm spread of Mycobacterium avium subsp. paratuberculosis in raw milk studied by IS900 and F57 competitive real time quantitative PCR and culture examination," International Journal of Food Microbiology, vol. 128, no. 2, pp. 250-257, 2008.
 J. L. E. Ellingson, C. A. Bolin, and J. R. Stabel, "Identification of a gene unique to Mycobacterium avium subspecies paratuberculosis and application to diagnosis of paratuberculosis," Molecular and Cellular Probes, vol. 12, no. 3, pp. 133-142, 1998.
 L. D. Stewart, A. Foddai, C. T. Elliott, and I. R. Grant, "Development of a novel phage-mediated immunoassay for the rapid detection of viable Mycobacterium avium subsp. paratuberculosis," Journal of Applied Microbiology, vol. 115, no. 3, pp. 808-817, 2013.
 G. Botsaris, M. Liapi, C. Kakogiannis, C. E. R. Dodd, and C. E. D. Rees, "Detection of Mycobacterium avium subsp. paratuberculosis in bulk tank milk by combined phage-PCR assay: Evidence that plaque number is a good predictor of MAP," International Journal of Food Microbiology, vol. 164, no. 1, pp. 76-80, 2013.
 A. Foddai, S. Strain, R. H. Whitlock, C. T. Elliott, and I. R. Grant, "Application ofa peptide-mediated magnetic separation-phage assay for detection of viable Mycobacterium avium subsp. paratuberculosis to bovine bulk tank milk and feces samples," Journal of Clinical Microbiology, vol. 49, no. 5, pp. 2017-2019, 2011.
 S. S. Nielsen, "Transitions in diagnostic tests used for detection of Mycobacterium avium subsp. paratuberculosis infections in cattle," Veterinary Microbiology, vol. 132, no. 3-4, pp. 274-282, 2008.
 J. R. Stabel, "Transitions in immune responses to Mycobacterium paratuberculosis," Veterinary Microbiology, vol. 77, no. 34, pp. 465-473, 2000.
 C. Burrells, C. J. Clarke, A. Colston et al., "Interferon-gamma and interleukin-2 release by lymphocytes derived from the blood, mesenteric lymph nodes and intestines of normal sheep and those affected with paratuberculosis (Johne's disease)," Veterinary Immunology and Immunopathology, vol. 68, no. 2-4, pp. 139-148, 1999.
 J. P Bannantine, E. Baechler, Q. Zhang, L. Li, and V Kapur, "Genome scale comparison of Mycobacterium avium subsp. paratuberculosis with Mycobacterium avium subsp. avium reveals potential diagnostic sequences," Journal of Clinical Microbiology, vol. 40, no. 4, pp. 1303-1310, 2002.
 A. Foddai, C. T. Elliott, and I. R. Grant, "Maximizing capture efficiency and specificity of magnetic separation for Mycobacterium avium subsp. paratuberculosis cells," Applied and Environmental Microbiology, vol. 76, no. 22, pp. 7550-7558, 2010.
 H.-Y. Hsih and H.-Y. Tsen, "Combination of immunomagnetic separation and polymerase chain reaction for the simultaneous detection of Listeria monocytogenes and Salmonella spp. in food samples," Journal of Food Protection, vol. 64, no. 11, pp. 1744-1750, 2001.
 N. Rijpens, L. Herman, F. Vereecken, G. Jannes, J. De Smedt, and L. De Zutter, "Rapid detection of stressed Salmonella spp. in dairy and egg products using immunomagnetic separation and PCR," International Journal of Food Microbiology, vol. 46, no. 1, pp. 37-44, 1999.
 H. Karch, C. Janetzki-Mittmann, S. Aleksic, and M. Datz, "Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture," Journal of Clinical Microbiology, vol. 34, pp. 516-519,1996.
 B. Posse, L. De Zutter, M. Heyndrickx, and L. Herman, "Quantitative isolation efficiency of O26, O103, O111, O145 and O157 STEC serotypes from artificially contaminated food and cattle faeces samples using a new isolation protocol," Journal of Applied Microbiology, vol. 105, no. 1, pp. 227-235, 2008.
 I. R. Grant, H. J. Ball, and M. T. Rowe, "Isolation of Mycobacterium paratuberculosis from milk by immunomagnetic separation," Applied and Environmental Microbiology, vol. 64, pp. 3153-3158, 1998.
 C. Metzger-Boddien, D. Khaschabi, M. Schonbauer, S. Boddien, T. Schlederer, and J. Kehle, "Automated high-throughput immunomagnetic separation-PCR for detection of Mycobacterium avium subsp. paratuberculosis in bovine milk," International Journal of Food Microbiology, vol. 110, no. 3, pp. 201-208, 2006.
 L. M. O'Brien, L. D. Stewart, S. A. J. Strain, and I. R. Grant, "Novel monoclonal antibody and peptide binders for Mycobacterium avium subsp. paratuberculosis and their application for magnetic separation," PLoS ONE, vol. 11, no. 1, Article ID e0147870, 2016.
 J. Stratmann, B. Strommenger, K. Stevenson, and G.-F. Gerlach, "Development of a peptide-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in milk," Journal of Clinical Microbiology, vol. 40, no. 11, pp. 4244-4250,2002.
 J. Stratmann, K. Dohmann, J. Heinzmann, and G.-F. Gerlach, "Peptide aMptD-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in bulk milk samples," Applied and Environmental Microbiology, vol. 72, no. 8, pp. 5150-5158, 2006.
 B. Djonne, M. R. Jensen, I. R. Grant, and G. Holstad, "Detection by immunomagnetic PCR of Mycobacterium avium subsp. paratuberculosis in milk from dairy goats in Norway," Veterinary Microbiology, vol. 92, no. 1-2, pp. 135-143, 2003.
 S. Khare, T. A. Ficht, R. L. Santos et al., "Rapid and sensitive detection of Mycobacterium avium subsp. paratuberculosis in bovine milk and feces by a combination of immunomagnetic bead separation-conventional PCR and real-time PCR," Journal of Clinical Microbiology, vol. 42, no. 3, pp. 1075-1081, 2004.
 L. R. Gilardoni, B. Fernandez, C. Morsella et al., "Mycobacterium paratuberculosis detection in cow's milk in Argentina by immunomagnetic separation-PCR," Brazilian Journal of Microbiology, vol. 47, no. 2, pp. 506-512, 2016.
 M. Salgado, P. Steuer, E. Troncoso, and M. T. Collins, "Evaluation of PMS-PCR technology for detection of Mycobacterium avium subsp. paratuberculosis directly from bovine fecal specimens," Veterinary Microbiology, vol. 167, no. 3-4, pp. 725-728, 2013.
 M. Ricchi, C. De Cicco, P. Kralik et al., "Evaluation of viable Mycobacterium avium subsp. paratuberculosis in milk using peptide-mediated separation and Propidium Monoazide qPCR," FEMS Microbiology Letters, vol. 356, no. 1, pp. 127-133, 2014.
 B. M. C. Swift, E. J. Denton, S. A. Mahendran, J. N. Huxley, and C. E. D. Rees, "Development of a rapid phage-based method for the detection of viable Mycobacterium avium subsp. paratuberculosis in blood within 48 h," Journal of Microbiological Methods, vol. 94, no. 3, pp. 175-179, 2013.
 R. Stephan, S. Schumacher, T. Tasara, and I. R. Grant, "Prevalence of Mycobacterium avium subspecies paratuberculosis in swiss raw milk cheeses collected at the retail level," Journal of Dairy Science, vol. 90, no. 8, pp. 3590-3595, 2007.
 J. A. Donaghy, M. T. Rowe, J. L. W. Rademaker et al., "An inter-laboratory ring trial for the detection and isolation of Mycobacterium avium subsp. paratuberculosis from raw milk artificially contaminated with naturally infected faeces," Food Microbiology, vol. 25, no. 1, pp. 128-135, 2008.
 D. Herthnek, S. S. Nielsen, A. Lindberg, and G. Bolske, "A robust method for bacterial lysis and DNA purification to be used with real-time PCR for detection of Mycobacterium avium subsp. paratuberculosis in milk," Journal of Microbiological Methods, vol. 75, no. 2, pp. 335-340, 2008.
 O. Okwumabua, E. Shull, M. O'Connor, T. V. Moua, T. Danz, and K. Strelow, "Comparison of three methods for extraction of Mycobacterium avium subspecies paratuberculosis dna for polymerase chain reaction from broth-based culture systems," Journal of Veterinary Diagnostic Investigation, vol. 22, no. 1, pp. 67-69, 2010.
 K. M. Plain, A. M. Waldron, D. J. Begg, K. De Silva, A. C. Purdie, and R. J. Whittington, "Efficient, validated method for detection of mycobacterial growth in liquid culture media by use of bead beating, magnetic-particle-based nucleic acid isolation, and quantitative PCR," Journal of Clinical Microbiology, vol. 53, no. 4, pp. 1121-1128, 2015.
Marketa Husakova, Radka Dziedzinska, and Iva Slana
Veterinary Research Institute, Hudcova 70, 621 00 Brno, Czech Republic
Correspondence should be addressed to Iva Slana; firstname.lastname@example.org
Received 19 December 2016; Revised 10 March 2017; Accepted 13 April 2017; Published 31 May 2017
Academic Editor: Bala Jagadeesan
Caption: Figure 1: Schematic illustration of the general magnetic separation procedure for the detection of Mycobacterium avium subsp. paratuberculosis. M, magnetic rack.
Table 1: Magnetic separation methods used for the detection of Mycobacterium avium subsp. paratuberculosis cells in milk. Method Type of beads Coating ligand Type of milk Bovine raw and pasteurized Dynabeads M-280 Polyclonal rabbit Bovine raw and sheep anti-rabbit anti-MAP pasteurized IgG (a) antibodies Sheep raw Goat raw Bovine unpasteurised IMS BioMag goat Polyclonal rabbit anti-rabbit IgG (e) anti-MAP Bovine antibodies ParaTub-S and Monoclonal Bovine BTM ParaTub-SL (f) antibody Monoclonal Goat anti-mouse anti-MAP antibody IgG magnetic 1A6E10 (mAh); Bovine beads (k) polyclonal anti-MAP antiserum (pAb) MagneSphere (m) Biotinylated aMp3 peptide, fMp3 Bovine phage aMptD peptide paramagnetic aMptD peptide BTM, pasteurized beads (0) MyOne Biotinylated UHT PMS Tosylactivated peptides (aMp3, Dynabeads aMptD) Bovine BTM Bovine UHT Pasteurized Method Artificially Preparation of sample contaminated Yes Aliquots serially diluted, cultured prior to IMS, or centrifuged and resuspended in PBS before IMS Yes No preparation No No preparation No Milk centrifuged, pellet resuspended in PBS containing 0.05% Tween 20 Yes MAP suspended in 220 mL milk and diluted 10-fold IMS Yes Milk centrifuged, pellet resuspended in PBS No (g) No preparation Bacterial clumps broken up by passage through No (l) needle, samples heated 15 min at 50[degrees]C and centrifuged, pellets resuspended in 1 mL of PBS, and 10 [micro]L of coated beads added Milk incubated with aMp3 peptide or fMp3 phage Yes coated beads Yes No preparation Yes 50:50, 5 piL of both types of beads added PMS separately per reaction to 1 mL MB-OADC with MAP No Milk centrifuged, pellet resuspended in 1 mL of MB with 10% OADC Yes Serial 10-fold dilutions of MAP in MB with 2 mmol/L Ca[Cl.sub.2] added (100 [micro]L) to 900 [micro]L aliquots of milk Yes 100 [micro]L of MAP aliquots added to 900 [micro]L of milk, vortexed, and centrifuged, pellets resuspended in 1 mL of 0.05% PBS-Tween20 Method Volume of sample Initial number of [mL] MAP 1 [10.sup.6] CFU/mL 1, 5, 10, and 50 [10.sup.6] CFU/mL 1 n. a. 50 n. a. 50 50 x [10.sup.6] CFU IMS 2 [10.sup.6] to [10.sup.0] organisms/mL 1 [10.sup.6]-[10.sup.0] organisms/mL 10 [10.sup.12] CFU/mL 1 [10.sup.0] to [10.sup.5] PFU/mL 5 x [10.sup.2] and 5 x 1 [10.sup.3] CFU/mL PMS 1 [10.sup.3] to [10.sup.5] CFU 50 n. a. 1 q 1 [10.sup.4] CFU/mL Capture Method Limit of efficiency (CE) Reference Detection Sensitivity (S) 104 CFU/mL 37% (CE) (b)  103 CFU/50 mL 100% (S)  n. a. n. a.  n. a. n. a.  1 CFU/mL (c) n. a.  0.1CFU/mL (d) IMS 10 or fewer MAP n. a.  organisms 5-10 bacteria/mLh 96% (SV  10-20 cells/mL1 101 CFU/mL n. a.  [10.sup.1] PFU/mL (aMp3); n. a.  [10.sup.2] PFU/mL (fMp3 phage) 5 x [10.sup.2] MAP/mL 5 x [10.sup.2]  CFU/mL (S) PMS n. a. (p) 91% [+ or -]  5% (CE) 1 to 110 n. a.  PFU/50 mL n. a.r n. a.  5 x [10.sup.2] CFU/mL n. a.  (a) Dynabeads M-280 sheep anti-rabbit IgG (Dynal, Oslo, Norway); (b) almost 100% when [10.sup.2] to [10.sup.4] of MAP/mL used; [C] EtBr staining; (d) Dot Blot; (e) BioMag goat anti-rabbit IgG with rabbit polyclonal anti-MAP antibodies (Polysciences, Inc., Warrington, Pennsylvania, USA); (f) the ParaTub-SLand ParaTub-S kits (AnDiaTec GmbH and Co. KG, Kornwestheim, Germany); (g) artificially contaminated milk was used to set the Limit of Detection; (h) IMS-real-time PCR; (i) automated IMS-PCR-ELISA; (j) ParaTub-S; (k) goat anti-mouse IgG magnetic beads (New England BioLabs Inc., Ipswich, MA, USA); (l) artificially contaminated milk was used for standardization of IMS-IS1 PCR; (m) MagneSphere streptavidin paramagnetic particles (Promega, Madison, Wisconsin, USA); (o) aMptD peptide coupled directly by carbodiimide method to paramagnetic beads (Chemicell, Berlin, Germany); (p) the mean [LOD.sub.50] = 14,4 PFU/50 mL equivalent to 0,3 PFU/mL; (q) the number of PFU [mL.sup.-1] used to spike the samples was determined by subjecting the [10.sup.3], [10.sup.-4], and [10.sup-5] spiking dilutions to the optimized phage assay and counting the plaques produced. In the final assay format, a consistent number of D29 seed phages ([10.sup.8] PFU [mL.sup.-1]) was added to the samples; [R] dynamic range of the assay was 3 x [10.sup.2]-6 x [10.sup.8] phages/mL; BTM = bulk tank milk; CE = capture efficiency; CFU = colony forming units; ELISA = enzyme-linked immunosorbent assay; HEYM = Herrolds egg yolk medium; IMS = immunomagnetic separation; LOD = Limit of Detection; [LOD.sub.50] = 50% Limit of Detection; MAP = Mycobacterium avium subsp. paratuberculosis; MB = Middlebrook 7H9 broth; n. a. = not available; OADC = oleic acid-albumin-dextrose-catalase; PBS = phosphate-buffered saline; PFU = plaque-forming units; PMS = peptide-mediated magnetic separation; S = sensitivity; UHT = ultra-heat-treated milk. Table 2: Magnetic separation methods used for the detection of Mycobacterium avium subsp. paratuberculosis cells in feces. Method Type of beads Coating ligand Type of matrix IMS BioMag goat Rabbit Bovine anti-rabbit polyclonal IgG (a) anti-MAP antibodies Bovine PMS MyOne Biotinylated Bovine Tosylactivated peptides Dynabeads (aMp3, aMptD) Bovine Method Artificially Preparation of sample contaminated IMS Yes MAP aliquots added to 200 mg of feces, resuspended in PBS (2mL), mixed on a rotating platform, and centrifuged, clear upper phase transferred to a tube with beads No Sample mixed with 4 mL of sterile water and centrifuged low-speed, 1 mL of supernatant used for PMS PMS No No preparation Dilution of autoclaved bovine feces in sterile water 1:5; serial 10-fold dilutions of MAP Yes prepared in MB containing 2 mmol/L Ca[Cl.sub.2] and added (100 [micro]L) to 900 /(L aliquots of fecal suspension Method Initial volume of Initial number of sample MAP [MAP/mL] IMS 200 mg [10.sup.6] to [10.sup.0] 1g n. a. PMS 2g n. a. 1 mL b Method Limit of Sensitivity Reference Detection [%] IMS 10 or fewer 100  MAP/200mg from 6 to n. a.  41,1 PFU/g PMS n. a. n. a.  from 3 x [10.sup.2] to 6 x [10.sup.8] phage n. a.  [mL.sup.-1] (a) BioMag goat anti-rabbit immunoglobulin G [IgG] with rabbit polyclonal anti-MAP antibodies (Polysciences, Inc., Warrington, Pa.); (b) the number of PFU [mL.sup.-1] used to spike the samples was determined by subjecting the [10.sup.-3],[10.sup.-4], and [10.sup.-5] spiking dilutions to the optimized phage assay and counting the plaques produced. In the final assay format, a consistent number of D29 seed phages ([10.sup.8] PFU [mL.sup.-1]) was a the samples; IMS = immunomagnetic separation; MAP = Mycobacterium avium subsp.paratuberculosis; MB = Middlebrook 7H9 broth; n. a. = not available; PBS = phosphate-buffered saline; PFU = plaque-forming units; PMS = peptide-mediated separation. Table 3: Magnetic separation methods used for the detection of Mycobacterium avium subsp. paratuberculosis cells in blood. Method Type of beads Coating ligand Type of sample MyOne Biotinylated Sheep PMS To syl activated peptides (aMp3, Horse Dynabeads aMptD) Bovinea Method Artificially Preparation of sample contaminated Yes 10-fold dilution of sample in PMS Yes modified 7H9 Media Plus + 5 [micro]L No aMp3 and 5 [micro]L aMptD beads Method Initial volume of Limit of Detection Initial number of sample [mL] [MAP cells/mL] MAP [PFU/mL] 1 10 3.5 x [10.sup.1] PMS 1 n. a. 3.5 x [10.sup.1] 1 n. a. n. a. Method Capture efficiency Reference [%i 92 PMS 92  92 (a) Whole blood or isolated buffer coat layer; MAP = Mycobacterium avium subsp. paratuberculosis. n. a. = information not available; PFU = plaque-forming units; PMS = peptide-mediated magnetic separation. Table 4: Magnetic separation methods used for the detection of Mycobacterium avium subsp. paratuberculosis cells in cheese. Method Type of beads Coating ligand Type of matrix IMS Pathatrix auto Anti-MAP Bovine raw milk systema antibodies cheese Method Artificially Preparation of sample contaminated IMS Yes (b) Stomacher filter bag, 225 mL of trisodium citrate buffer, 1% casitone, 2% sodium citrate added to the sample, homogenization in a Stomacher 400 lab blender, 50 [micro]L of anti-MAP Pathatrix beads added Method Initial mass of Initial number of Limit of Detection sample [g] MAP IMS 25 c [10.sup.3] MAP/ 25 g of cheese Method Reference IMS  (a) Pathatrix auto system, paramagnetic beads coated with anti-MAP antibody (Matrix MicroScience Ltd., Newmarket, UK); (b) retail cheese samples included; [C] different levels of MAP contamination were tested ([10.sup.3] MAP/25 g or 40 MAP/g); auto = automatically processed; IMS = immunomagnetic separation; MAP = Mycobacterium avium subsp.paratuberculosis. Table 5: Magnetic separation methods used for the detection of Mycobacterium avium subsp. paratuberculosis DNA in milk. Type of kit Type of milk Artificially contaminated Adiapurea Bovine raw Yes (b) EZI DNA Tissue Bovine BTM No (e) Kit (d) Type of kit Preparation of sample Initial volume of sample [mL] Adiapurea No preparation 10 Milk centrifuged, cream retained, pellet incubated (37[degrees]C), centrifuged; a mixture of 1000 [micro]L lysis buffer, 2 piL EZI DNA Tissue proteinase K used to dissolve the 10 Kit (d) cream fraction, dissolved cream pooled with the pellet, mixture transferred to bead beating tubes (600 [micro]L of beads), tubes incubated (56[degrees]C), shaken, centrifuged, 400 [micro]L of the liquid phase processed with kit and BioRobot Type of kit Initial number of Number of copies MAP [MAP/mL] detected Adiapurea [10.sup.6]-[10.sup.7] 30 copies of IS900/mL EZI DNA Tissue [10.sup.0]-[10.sup.4] n. a. Kit (d) Type of kit Analytical Sensitivity of Reference sensitivity detection [%] [MAP/mL] Adiapurea n. a. 100, 90, 85, 25c  EZI DNA Tissue 100 n. a.  Kit (d) (a) The combined Adiapure-Adiavet MAP DNA extraction and detection kit with magnetic beads; (b) artificially contaminated with naturally infected feces ([10.sup.6]-[10.sup.7] MAP); 10 g thawed feces diluted in 90 mL sterile distilled water; (c) sensitivity of detection was 100,90,85, and 25% for respective MAP concentrations of 300, 30, 3, and 0.3 copies of IS900/[mL.sup.-1]; (d) EZI DNA Tissue Kit with magnetic beads (Qiagen, Hilden, Germany) automatically processed in the BioRobot[R] EZI workstation (Qiagen); (e) for assessment of analytical sensitivity, quantification of MAP and the testing of various parameters during the development of the extraction method artificially contaminated milk was used; auto = automatically processed; BTM = bulk tank milk; MAP = Mycobacterium avium subsp. paratuberculosis; n. a. = not available. Table 6: Magnetic separation method used for the detection of Mycobacterium avium subsp. paratuberculosis DNA in feces and tissue. Type of kit Type of Artificially Preparation of sample matrix contaminated No No preparation 300 mg of feces MagMAX (a) Bovine feces diluted in 1 mL of No PBS, vortexed, centrifuged, supernatant added to a tube with zirconia beads and lysis- binding solution, vortexed, centrifuged, added to a plate with isopropanol, magnetic nucleic acid-binding beads and binding lysis enhancer, automated system used (MagMAX Express Magnetic Particle Processor) BioSprint 96 + Bovine feces No Growth in Bactec 12B, MagM AX-96 Sheep feces No [C] 200 [micro]L liquid auto. (b) Sheep tissue No culture medium added to 200 [micro]L buffer RLT, transferred to a tube with 0.3 g zirconia-silica beads, disrupted in Fast Prep-24 bead beater for 60 s, and centrifuged, 100 [micro]L added to a deep 96-well plate Type of kit Initial volume Initial number of sample of MAP [MAP/mL] 500 [micro]L n. a. MagMAX (a) 300 mg n. a. BioSprint 96 + 100 [micro]L n. a. MagM AX-96 100 [micro]L [10.sup.6] to [10.sup.1] auto. (b) 100 [micro]L n. a. Type of kit Limit of Sensitivity of Reference Detection detection [%] [MAP/mL] n. a. 65  MagMAX (a) n. a. 76  BioSprint 96 + n. a. n. a. MagM AX-96 100-1000 n. a.  auto. (b) n. a. n. a. (a) MagMAX Total Nucleic Acid Isolation Kit; (b) BioSprint 96 one-for-all vet kit (Qiagen) + MagMAX-96 automated magnetic processor; (c) artificially contaminated only to set the Limit of Detection; auto = automatically processed; LOD = Limit of Detection; MAP = Mycobacterium avium subsp. paratuberculosis; n. a. = not available; PBS = phosphate-buffered saline; RLT = commercial name for the lysis buffer (Qiagen).
|Printer friendly Cite/link Email Feedback|
|Author:||Husakova, Marketa; Dziedzinska, Radka; Slana, Iva|
|Publication:||BioMed Research International|
|Date:||Jan 1, 2017|
|Previous Article:||Sera from Visceral Leishmaniasis Patients Display Oxidative Activity and Affect the TNF-[alpha] Production by Macrophages In Vitro.|
|Next Article:||Can the Diagnostics of Triangular Fibrocartilage Complex Lesions Be Improved by MRI-Based Soft-Tissue Reconstruction? An Imaging-Based Workup and...|